Stock Analysis

FamiCord First Quarter 2025 Earnings: €0.04 loss per share (vs €0.05 loss in 1Q 2024)

XTRA:V3V
Source: Shutterstock
Advertisement

FamiCord (ETR:V3V) First Quarter 2025 Results

Key Financial Results

  • Revenue: €22.1m (up 19% from 1Q 2024).
  • Net loss: €669.0k (loss narrowed by 15% from 1Q 2024).
  • €0.04 loss per share (improved from €0.05 loss in 1Q 2024).
earnings-and-revenue-history
XTRA:V3V Earnings and Revenue History May 30th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

FamiCord Earnings Insights

Looking ahead, revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Healthcare industry in Germany.

Performance of the German Healthcare industry.

The company's shares are up 1.5% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with FamiCord, and understanding this should be part of your investment process.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About XTRA:V3V

FamiCord

Engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally.

Fair value with moderate growth potential.

Advertisement